Shenk, Kevin D.,Parlati, Francesco,Zhou, Han-jie,Sylvain, Catherine,Smyth, Mark S.
申请号：
AU2015202295
公开号：
AU2015202295A1
申请日:
2015.05.01
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015202295A120150521.pdf#####Abstract One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain 5 embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
